High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemiaDelphine Réa, Philippe Rousselot, Françoise Huguet et al.|Leukemia|2006Cited by 77